(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of -0.27% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.56%.
Agenus's revenue in 2026 is $132,693,000.On average, 5 Wall Street analysts forecast AGEN's revenue for 2026 to be $5,748,655,770, with the lowest AGEN revenue forecast at $4,300,304,256, and the highest AGEN revenue forecast at $6,632,406,359. On average, 5 Wall Street analysts forecast AGEN's revenue for 2027 to be $5,321,412,107, with the lowest AGEN revenue forecast at $3,152,373,919, and the highest AGEN revenue forecast at $6,570,728,402.
In 2028, AGEN is forecast to generate $5,926,036,173 in revenue, with the lowest revenue forecast at $5,550,115,775 and the highest revenue forecast at $6,254,234,940.